Postnatal serum IGF-1 levels associate with brain volumes at term in extremely preterm infants

William Hellström*, Lisa M Hortensius, Chatarina Löfqvist, Gunnel Hellgren, Maria Luisa Tataranno, David Ley, Manon J N L Benders, Ann Hellström, Isabella M Björkman-Burtscher, Rolf A Heckemann, Karin Sävman

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

21 Downloads (Pure)

Abstract

Background: Growth factors important for normal brain development are low in preterm infants. This study investigated the link between growth factors and preterm brain volumes at term. Material/methods: Infants born <28 weeks gestational age (GA) were included. Endogenous levels of insulin-like growth factor (IGF)−1, brain-derived growth factor, vascular endothelial growth factor, and platelet-derived growth factor (expressed as area under the curve [AUC] for serum samples from postnatal days 1, 7, 14, and 28) were utilized in a multivariable linear regression model. Brain volumes were determined by magnetic resonance imaging (MRI) at term equivalent age. Results: In total, 49 infants (median [range] GA 25.4 [22.9–27.9] weeks) were included following MRI segmentation quality assessment and AUC calculation. IGF-1 levels were independently positively associated with the total brain (p < 0.001, β = 0.90), white matter (p = 0.007, β = 0.33), cortical gray matter (p = 0.002, β = 0.43), deep gray matter (p = 0.008, β = 0.05), and cerebellar (p = 0.006, β = 0.08) volume adjusted for GA at birth and postmenstrual age at MRI. No associations were seen for other growth factors. Conclusions: Endogenous exposure to IGF-1 during the first 4 weeks of life was associated with total and regional brain volumes at term. Optimizing levels of IGF-1 might improve brain growth in extremely preterm infants. Impact: High serum levels of insulin-like growth factor (IGF)-1 during the first month of life were independently associated with increased total brain volume, white matter, gray matter, and cerebellar volume at term equivalent age in extremely preterm infants.IGF-1 is a critical regulator of neurodevelopment and postnatal levels are low in preterm infants. The effects of IGF-1 levels on brain development in extremely preterm infants are not fully understood.Optimizing levels of IGF-1 may benefit early brain growth in extremely preterm infants. The effects of systemically administered IGF-1/IGFBP3 in extremely preterm infants are now being investigated in a randomized controlled trial (Clinicaltrials.gov: NCT03253263).

Original languageEnglish
Pages (from-to)666-674
Number of pages9
JournalPediatric Research
Volume93
Issue number3
Early online date9 Jun 2022
DOIs
Publication statusPublished - Feb 2023

Fingerprint

Dive into the research topics of 'Postnatal serum IGF-1 levels associate with brain volumes at term in extremely preterm infants'. Together they form a unique fingerprint.

Cite this